Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotech Institute is a specialized biotechnology company focused on the genetics, breeding, and intellectual property of the cannabis plant. The company holds a significant portfolio of utility patents covering various chemotypes of cannabis, specifically those with unique cannabinoid and terpene profiles. Their business model centers on licensing these proprietary genetics and cultivation methods to producers in the legal cannabis and hemp industries. By utilizing advanced molecular breeding techniques, Biotech Institute aims to standardize cannabis production for pharmaceutical and therapeutic applications. The company is notably recognized for its legal efforts to protect its foundational patents within the industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotech Institute.